We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Qiagen Bids $100M to Acquire Exiqon

News   Mar 31, 2016

 
Qiagen Bids $100M to Acquire Exiqon
 
 
Advertisement
 

RELATED ARTICLES

Dendritic Cells Can Take Shortcuts

News

During an inflammatory response, things need to happen quickly. Researchers have recently discovered that certain immune cells that function as security guards can use a shortcut to get from the tissue to lymph nodes.

READ MORE

CABYR Isoforms As Targets for Specific Immunotherapy

News

Calcium-binding tyrosine phosphorylation-regulated protein (CABYR) is considered a cancer testis protein. Researchers evaluate the CABYR isoforms: a/b and c mRNA expression in colorectal cancer to determine if these proteins hold promise as vaccine targets.

READ MORE

Blood-Based Biomarker Panel Can Distinguish Between Bacterial and Viral Infections

News

Researchers have identified a set of molecular biomarkers that can be used in the differential diagnosis of acute bacterial and viral infections. These biomarkers are different mRNA molecules found in the blood; differences in their levels can detect and predict with high probability if an infection is viral or bacterial.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE